Modern multi-lateral trade treaties do not habitually soften IP protection. The Trans-Pacific Partnership (TPP), signed October 5th, is no exception. With prescription drug costs increasingly weighing on Western nations, does the TPP strike the best balance between protecting patents and incentivizing innovation?
To read the press release from the Court of Justice of the European Union regarding Maximillian Schrems v Data Protection Commissioner, click here.
The wearable tech market has quickly become a significant global industry and the market appears ripe for future growth. Some sources predict that the global retail revenue from smart wearable devices will reach the $53 billion mark by 2019, largely driven by an increase in sales of premium smart watches and smart glasses over the next […]
The re-posting of this analysis is part of a cross-posting collaboration with MediaLaws: Law and Policy of the Media in a Comparative Perspective. The Italian Data Protection Authority on Google’s privacy policies After an investigation started one year ago, following the modification of Google’s privacy policies, the Italian DPA has issued yesterday a new provision, […]
The re-posting of this analysis is part of a cross-posting collaboration with MediaLaws: Law and Policy of the Media in a Comparative Perspective.
The re-posting of this analysis is part of a cross-posting collaboration with MediaLaws: Law and Policy of the Media in a Comparative Perspective. 2012 was a very busy year for Italian lawmakers. Several laws significantly amended the Italian data protection legal framework, as set forth in the Italian Data Protection Code (Legislative Decree No. 196/2003).
The period of data protection allocated to research-based, innovative drug companies is a hotly debated topic in the pharmaceutical industry and beyond. This period of protection allows research-based, brand name drug companies to maintain a monopoly on the market for any particular drug for a specified duration. During the period of data protection, competing generic drug […]